Besides providing valuable information on patients' access to insulin, syringes, monitoring and care which was then used to help these three countries improve the care for people with diabetes, the RAPIA was able to sketch a picture of the health care system and its ability to treat patients with Type 1 diabetes. This evidence concerns the gene INS and type 1 diabetes mellitus.